Beyond the critical period: Longitudinal study of 8-year outcome in first-episode non-affective psychosis

British Journal of Psychiatry

Volumn 194, Issue 1, 2009, Pages 18-24

  Crumlish, Niall ^a   Whitty, Peter ^b   Clarke, Mary ^b   Browne, Stephen ^b   Kamali, Moayyad ^b   Gervin, Maurice ^b   McTigue, Orfhlaith ^c   Kinsella, Anthony ^d   Waddington, John L ^e   Larkin, Conall ^b,d   O'Callaghan, Eadbhard ^b,d  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c Cluain Mhuire Family Centre   (Ireland)

^d DETECT   (Ireland)

^e ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; AGE OF ONSET; AGED; AGED, 80 AND OVER; CHILD; CRITICAL PERIOD (PSYCHOLOGY); FEMALE; FOLLOW-UP STUDIES; HUMANS; IRELAND; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58149382255     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.107.048942     Document Type: Article

References (50)

1. Birchwood M, Todd P, Jackson, C. Early intervention in psychosis: the critical period hypothesis. Br J Psychiatry 1998; 172 (suppl 33): s53-9.
2. Craig TK, Garety P, Power P, Rahaman N, Colbert S, Fornells-Ambrojo M, et al. The Lambeth Early Onset (LEO) Team: a randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ 2004; 329: 1067-70.
3. Edwards J, Harris MG, Bapat S. Developing services for first-episode psychosis and the critical period. Br J Psychiatry 2005; 187 (suppl 48): s91-7.
4. Petersen L, Nordentoft M, Jeppesen P, Øhlenschaeger J, Thorup A, Christensen TØ, et al. Improving 1-year outcome in first-episode psychosis. OPUS trial. Br J Psychiatry 2005; 187 (suppl 48): s98-103.
5. Pelosi AJ, Birchwood M. Is early intervention a waste of valuable resources? Br J Psychiatry 2003; 182: 196-8.
6. Carpenter W, Strauss J. The prediction of outcome in schizophrenia, IV: eleven year follow-up of the Washington IPSS cohort. J Nerv Ment Dis 1991; 179: 517-25.
7. Eaton WW, Thara R, Federman B, Melton B, Liang KY. Structure and course of positive and negative symptoms in schizophrenia. Arch Gen Psychiatry 1995; 52: 127-34.
8. Browne S, Clarke M, Gervin M, Waddington JL, Larkin C, O'Callaghan E. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000; 176: 173-6.
9. Ho BC, Andreasen NC, Flaum M, Nopoulos P, Miller D. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry 2000; 157: 808-15.
10. Addington J, van Mastrigt S, Addington D. Duration of untreated psychosis: impact on 2-year outcome. Psychol Med 2004; 34: 277-84.
11. Verdoux H, Liraud F, Bergey C, Assens F, Abalan F, van Os J. Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up of first-admitted patients. Schizophr Res 2001; 49: 231-41.
12. Craig TJ, Bromet EJ, Fennig S, Tanenberg-Karant M, Lavelle J, Galambos N. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Am J Psychiatry 2000; 157: 60-6.
13. Malla A, Norman R, Schmitz N, Manchanda R, Béchard-Evans L, Takhar J, et al. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol Med 2006; 36: 649-58.
14. Bottlender R, Sato T, Jäger M, Wegener U, Wittmann J, Strauss A, et al. The impact of duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia. Schizophr Res 2003; 62: 37-44.
15. Wiersma D, Nienhuis FJ, Slooff CJ, Giel R. Natural course of schizophrenic disorders: a 15-year follow-up of a Dutch incidence cohort. Schizophr Bull 1998; 24: 75-85.
16. Johnstone EC, Crow TJ, Johnson AL, MacMillan JF. The Northwick Park Study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission. Br J Psychiatry 1986; 148: 115-20.
17. Clarke M, Whitty P, Browne S, McTigue O, Kamali M, Gervin M, et al. Untreated illness and outcome of psychosis. Br J Psychiatry 2006; 189: 235-40.
18. Harris MG, Henry LP, Harrigan SM, Purcell R, Schwartz OS, Farrelly SE, et al. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res 2005; 79: 85-94.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder (4th edn) (DSM-IV). APA, 1994.
20. Kay SR, Fissbein A, Opler LA. The positive and negative syndrome scale for schizophrenia. Schizophr Bull 1987; 13: 261-76.
21. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders. New York State Psychiatric Institute, 1995.
22. Heinrichs DW, Hanlon TG, Carpenter WT, Jr. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984; 10: 388-98.
23. Foerster A, Lewis S, Owen M, Murray R. Premorbid adjustment and personality in psychosis. Effects of sex and diagnosis. Br J Psychiatry 1991; 158: 171-6.
24. Beiser M, Erickson D, Fleming JA, Iacono WG. Establishing the onset of psychotic illness. Am J Psychiatry 1993; 150: 1349-54.
25. Strauss JS, Carpenter WT, Jr. The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO International Pilot Study of Schizophrenia. Arch Gen Psychiatry 1974; 31: 37-42.
26. van der Gaag M, Hoffman T, Remijsen M, Hijman R, de Haan L, van Meijel B, et al. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model, schizophr Res 2006; 85: 280-7.
27. van der Gaag M, Cuijpers A, Hoffman T, Remijsen M, Hijman R, de Haan L, et al. The five-factor model of the Positive and Negative Syndrome Scale I: Confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophr Res 2006; 85: 273-9.
28. Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res 2000; 45: 1-9.
29. Mason P, Harrison G, Glazebrook C, Medley I, Dalkin T, Croudace T. Characteristics of outcome in schizophrenia at 13 years. Br J Psychiatry 1995; 167: 596-603.
30. Keshavan MS, Haas G, Miewald J, Montrose DM, Reddy R, Schooler NR, et al. Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr Bull 2003; 29: 757-69.
31. Munk-Jorgensen P, Mortensen PB. Schizophrenia: a 13-year follow-up. Diagnostic and psychopathological aspects. Acta Psychiatr scand 1989; 79: 391-9.
32. Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry 1991; 48: 239-46.
33. Fenton WS, McGlashan TH. Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course. Arch Gen Psychiatry 1991; 48: 978-86.
34. an der Heiden W, Hafner H. The epidemiology of onset and course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2000; 250: 292-303.
35. Nordentoft M, Jeppesen P, Bertelsen M, LeQuack P, Abel MB, Thorup A, et al. The association between premorbid functioning, duration of untreated psychosis and outcome among patients with first-episode schizophrenia spectrum psychosis. Eur Arch Psychiatry Clinical Neurosci 2007; 257 (suppl 1): 7.
36. Davidson L, McGlashan TH. The varied outcomes of schizophrenia. Can J Psychiatry 1997; 42: 34-43.
37. Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005; 162: 441-9.
38. Steel C, Garety PA, Freeman D, Craig E, Kuipers E, Bebbington P, et al. The multidimensional measurement of the positive symptoms of psychosis. Int J Methods Psychiatr Res 2007; 16: 88-96.
39. Thara R. Twenty-year course of schizophrenia; the Madras Longitudinal Study. Can J Psychiatry 2004; 49: 564-9.
40. Röpcke B, Eggers C. Early-onset schizophrenia: a 15-year follow-up. Eur Child Adolesc Psychiatry 2005; 14: 341-50.
41. Garety P, Jolley S. Early intervention in psychosis. Psych Bull 2000; 24: 321-3.
42. McGorry PD. The recognition and optimal management of early psychosis: an evidence-based reform. World Psychiatry 2002; 1: 76-83.
43. Bleuler M. The Schizophrenic Disorders: Long-Term Patient and Family Studies. Yale University Press, 1978.
44. McGlashan T. Commentary. Progress, issues and implications of prodromal research: an inside view. Schizophr Bull 2003; 29: 851-8.
45. Ruhrmann S, Bechdolf A, Kühn KU, Wagner M, Schultze-Lutter F, Janssen B, et al. Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. Br J Psychiatry 2007; 191 (suppl 51): s88-95.
46. Cannon TD, Cornblatt B, McGorry P. Editors' introduction: the empirical status of the ultra-high risk (prodromal) research paradigm. Schizophr Bull 2007; 33: 661-4.
47. Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, et al. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 2004; 61: 143-50.
48. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients. Arch Gen Psychiatry 2005; 62: 975-83.
49. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005; 162: 1785-804.
50. Marshall M, Rathbone J. Early intervention for psychosis. Cochrane Database Syst Rev 2006; 4: CD004718.